Interview
summary
CRISPR is described as a cheap, accessible genome-hacking tool that can target and cut specific DNA sequences, with claims of curing hundreds of thousands of genetic diseases; sequencing costs fall from about $100M to ~$1k, enabling personalized edits. Reported results include HIV removed in animals and human embryos edited experimentally; major hurdles are delivering edits into living humans, active patent battles, and fast-moving labs worldwide with China especially competitive.
AI-written summary · about
chapters (8)
- 0:00Interview introduction
- 0:51What is CRISPR
- 3:23CRISPR discovery
- 5:13Ethics and global debate
- 6:59CRISPR cost and access
- 7:42Human embryo editing
- 9:07CRISPR disease targets
- 10:30Learn more about CRISPR
